Guidance for industry : pharmaceutical components at risk for melamine contamination.

Bibliographic Details
Corporate Authors: Center for Drug Evaluation and Research (U.S.)
Center for Veterinary Medicine (U.S.)
Language:English
Published: Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Veterinary Medicine, [2009]
Subjects:
Drug adulteration.
Melamine.
Veterinary drug residues.
Online Access:
Connect to online resource - All users (Federal Depository Library Program Persistant URL)
Physical Description:1 online resource (5 pages)
Variant Title:
Pharmaceutical components at risk for melamine contamination
Format: Government Document Electronic eBook
Description
Note:"Current Good Manufacturing Practice (CGMP)."
"August 2009."
Electronic resource.
Call Number:HE 20.4702:P 49/8